Event 
Partner 
Milestone 
2021-01-15
Taiwan Healthcare Data Preservation Platform Initiative
The Taiwan government initiative "Taiwan Precision Medicine Collaboration Initiatives" with ACT Genomics, Novartis Taiwan, and Pfizer Taiwan.
Place:
Taiwan
2020-11-19
ASUS, KMUH and ACT Genomics Collaborate to Develop AI-based Precision Cancer Medicine Solutions for Cancer Patients
The collaboration among ASUS, KMUH and ACT Genomics aim to utilize NGS tumor profiling service, cancer genomic database and Intelligent Cloud Service Center (AICS) EMR search to intelligently assist physicians to develop treatment plans.
Place:
Taiwan
2020-11-10
Teddy Lab, A Central Lab Partner Of ACT Genomics, And AstraZeneca China Signed Strategic MOU To Develop Cancer Precision Medicine Solution In China
Teddy Lab and AstraZeneca China signed strategic MOU for the CDx development of HRD, the standardization of sequencing and commercialization to provide cancer patients precision diagnosis and treatment as one-stop service.
Place:
China
2020-06-20
A Joint Clinical Research Collaboration among ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) Seeks to Investigate the Genomic Landscape of Melanoma in Taiwan
ACT Genomics, Kaohsiung Medical University (KMU), and National Health Research Institutes (NHRI) launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of Melanoma within the Taiwanese population
Place:
Taiwan
2020-03-02
ACT Genomics Partners With Oncoshot To Drive Clinical Trial At A Strategic Level
To find the missing piece in accurate clinical trial matching, ACT Genomics partners with Oncoshot, Singapore medical start-up, to offer comprehensive molecular information for Oncoshot’s clinical trial platform in SEA.
Place:
Singapore
2020-02-12
A Joint Clinical Research Collaboration among Tokyo Medical and Dental University (TMDU), ACT Genomics, and ACTmed Seeks to Investigate the Cancer Genomic Landscape of Japanese Population
Tokyo Medical and Dental University (TMDU), ACT Genomics, and ACTmed launched a joint clinical research collaboration aimed to establish comprehensive genomic profiles of highly prevalent cancers within the Japanese population.
TMDU Bioresource Research C
Place:
Japan
2019-10-29
ACT Genomics Works with UC San Diego Team to Predict Immunotherapy Response from Tumor Microenvironment (TME)
ACT Genomics and UC San Diego Moores Cancer Center have launched a study to evaluate gene expressions associated with the tumor microenvironment (TME) in PD-1 treatment outcome prediction for 100 melanoma patients. The study relies on a proprietary chip-b
Place:
Taiwan
2019-07-29
ACT Genomics Collaborates with AIA Hong Kong to Promote Precision Cancer Medicine!
ACT Genomics is excited to collaborate with AIA Hong Kong to bring ACT Genomics’ leading cancer profiling service to AIA Hong Kong customers.
Place:
Taiwan
2018-07-06
ACT Genomics signs MOU with Bumrungrad International Hospital to offer services in Thailand
ACT Genomics is pleased to announce that it has signed a memorandum of understanding (MOU) with Bumrungrad International Hospital (BIH) to offer genomic diagnostic services in Thailand.
Place:
Thailand
2018-07-06
ACT Genomics and Allegiant Regional Care Hospital Announce Partnership in Cebu, Philippines.
ACT Genomics and ARC Hospitals, a new premier hospital group in the Philippines, are collaborating to offer genomic testing services in Cebu, Philippines.
Place:
Philippines
